Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • novo nordisk

    Tag: novo nordisk

    You Searched For "novo nordisk"
    Novo Nordisks Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

    Novo Nordisk's Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

    Medical Dialogues Bureau18 Jan 2020 10:36 AM IST
    Denmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion based on a supplemental New...
    Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

    Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

    Medical Dialogues Bureau23 Sept 2019 2:16 PM IST
    Novo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Medical Dialogues Bureau21 Sept 2019 9:30 AM IST
    "We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...
    Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

    Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

    Medical Dialogues Bureau18 Sept 2019 9:30 AM IST
    This new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
    Novo Nordisk gets USFDA for use of Victoza to treat type 2 diabetes in pediatric patients

    Novo Nordisk gets USFDA for use of Victoza to treat type 2 diabetes in pediatric patients

    Meghna A Singhania18 Jun 2019 4:07 PM IST
    US The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with...
    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Farhat Nasim25 April 2019 10:50 AM IST
    The approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
    Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost

    Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost

    Medical Dialogues Bureau30 Dec 2018 9:20 AM IST
    ZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
    Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin

    Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin

    Medical Dialogues Bureau17 Oct 2018 3:16 PM IST
    US : Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively...
    Novo Nordisk wins EU panel

    Novo Nordisk wins EU panel's backing for key diabetes drug

    Ruby Khatun Khatun18 Dec 2017 10:30 AM IST
    COPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
    FDA approves Novo Nordisk diabetes drug Ozempic

    FDA approves Novo Nordisk diabetes drug Ozempic

    Ruby Khatun Khatun6 Dec 2017 10:30 AM IST
    The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
    Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs

    Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs

    Ruby Khatun Khatun24 Nov 2017 9:30 AM IST
    Denmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...
    Novo Nordisk partners with Karnataka State Government Employees Association for Diabetes screening and awareness

    Novo Nordisk partners with Karnataka State Government Employees Association for Diabetes screening and awareness

    Ruby Khatun Khatun18 Nov 2017 9:48 AM IST
    BENGALURU: Novo Nordisk, a global healthcare company with more than 90 years of innovation and leadership in diabetes care organized a diabetes...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok